Standardized Arrabidaea chica Extract Shows Cytoprotective Effects in Zoledronic Acid-Treated Fibroblasts and Osteoblasts

References

• Saracino S, Canuto RA, Maggiora M, et al. Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model. J Oral Pathol Med. 2012;41:788–792. doi:10.1111/j.1600-0714.2012.01173.x
   PubMed Web of Science ®Google Scholar
• Ruggiero SL, Dodson TB, Fantasia J, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg. 2014;72(10):1938–1956. doi:10.1016/j.joms.2014.04.031
   PubMed Web of Science ®Google Scholar
• Scheper MA, Badros A, Chaisuparat R, Cullen KJ, Meiller TF. Effect of zoledronic acid on oral fibroblasts and epithelial cells: A potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol. 2009;144:667–676. doi:10.1111/j.1365-2141.2008.07504.x
   PubMed Web of Science ®Google Scholar
• Scheper MA, Chaisuparat R, Cullen KJ, Meiller TF. A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis. Fibrogenes Tissue Repair. 2010. doi:10.1186/1755-1536-3-6
   Google Scholar
• Kobayashi Y, Hiraga T, Ueda A, et al. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice. J Bone Miner Metab. 2010;28(2):165–175. doi:10.1007/s00774-009-0128-9
   Web of Science ®Google Scholar
• Cozin M, Pinker BM, Solemani K, et al. Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts. J Oral Maxillofac Surg. 2011;69:2564–2578. doi:10.1016/j.joms.2011.03.005
   Web of Science ®Google Scholar
• Arai N, Inoue S, Tomihara K, Tsuno H, Noguchi M. In vitro synergistic effects of zoledronic acid and calcium on viability of human epithelial cells. Oral Dis. 2013;19(2):200–205. doi:10.1111/j.1601-0825.2012.01971.x
   Web of Science ®Google Scholar
• Stresing V, Fournier PG, Bellahcène A, et al. Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase. Bone. 2011;48(2):259–266. doi:10.1016/j.bone.2010.09.035
   Web of Science ®Google Scholar
• Simon MJK, Niehoff P, Kimmig B, Wiltfang J, Açil Y. Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment. Clin Oral Investig. 2010;14(1):51–58. doi:10.1007/s00784-009-0312-2
   Web of Science ®Google Scholar
• Jung J, Park JS, Righesso L, et al. Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro. Clin Oral Investig. 2018;22(7):2527–2534. doi:10.1007/s00784-018-2349-6
   PubMed Web of Science ®Google Scholar
• Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005;63:1567–1575. doi:10.1016/j.joms.2005.07.010
   PubMed Web of Science ®Google Scholar
• Marx RE, Cillo JE, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007;65:2397–2410. doi:10.1016/j.joms.2007.08.003
   PubMed Web of Science ®Google Scholar
• Ruggiero SL, Mehrotra B. Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management. Annu Rev Med. 2009;60(1):85–96. doi:10.1146/annurev.med.60.063007.134350
   Web of Science ®Google Scholar
• MacKay D, Miller AL. Nutritional support for wound healing. Altern Med Rev. 2003;8(4):359–377.:.
   PubMedGoogle Scholar
• Houghton PJ, Hylands PJ, Mensah AY, Hensel A, Deters AM. In vitro tests and ethnopharmacological investigations: wound healing as an example. J Ethnopharmacol. 2005;100(1–2):100–107. doi:10.1016/j.jep.2005.07.001
   Web of Science ®Google Scholar
• Ozgen U, Ikbal M, Hacimuftuoglu A, et al. Fibroblast growth stimulation by extracts and compounds of Onosma argentatum roots. J Ethnopharmacol. 2006;104(1–2):100–103. doi:10.1016/j.jep.2005.08.052
   PubMed Web of Science ®Google Scholar
• Devia B, Llabres G, Wouters J, et al. New 3-deoxyanthocyanidins from leaves ofArrabidaea chica. Phytochem Anal. 2002;13(2):114–120. doi:10.1002/pca.632
   PubMed Web of Science ®Google Scholar
• Jorge MP, Madjarof C, Ruiz ALTG, et al. Evaluation of wound healing properties of Arrabidaea chica Verlot extract. J Ethnopharmacol. 2008;118:361–366. doi:10.1016/j.jep.2008.04.024
   PubMed Web of Science ®Google Scholar
• Aro AA, Freitas KM, Foglio MA, et al. Effect of the Arrabidaea chica extract on collagen fiber organization during healing of partially transected tendon. Life Sci. 2013;92(13):799–807. doi:10.1016/j.lfs.2013.02.011
   PubMed Web of Science ®Google Scholar
• Aro AA, Simões GF, Esquisatto MAM, et al. Arrabidaea chica extract improves gait recovery and changes collagen content during healing of the Achilles tendon. Injury. 2013;44(7):884–892. doi:10.1016/J.INJURY.2012.08.055
   Web of Science ®Google Scholar
• Wen D, Li C, Di H, Liao Y, Liu H, Universal A. HPLC method for the determination of phenolic acids in compound herbal medicines. J Agric Food Chem. 2005;53(17):6624–6629. doi:10.1021/jf0511291
   PubMed Web of Science ®Google Scholar
• Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone. 2007;41(3):318–320. doi:10.1016/j.bone.2007.04.196
   PubMed Web of Science ®Google Scholar
• Reid IR. Osteonecrosis of the jaw — who gets it, and why? Bone. 2009;44(1):4–10. doi:10.1016/j.bone.2008.09.012
   Web of Science ®Google Scholar
• Zafar S, Coates DE, Cullinan MP, Drummond BK, Milne T, Seymour GJ. Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts. J Oral Pathol Med. 2014;43(9):711–721. doi:10.1111/jop.12181
   PubMed Web of Science ®Google Scholar
• Açil Y, Möller B, Niehoff P, et al. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells. J Cranio-Maxillofacial Surg. 2012;40(8):e229e235. doi:10.1016/j.jcms.2011.10.024
   Web of Science ®Google Scholar
• Paroni G, Brancolini C. Measurement of caspase activity: from cell populations to individual cells. In: Stoddart MJ, editor. Mammalian Cell Viability: Methods and Protocols. New York: Springer Science+Business Media; 2011:64–79. doi:10.1007/978-1-61779-108-6
   Google Scholar
• Shannon J, Shannon J, Modelevsky S, Grippo AA. Bisphosphonates and Osteonecrosis of the Jaw. J Am Geriatr Soc. 2011;59(12):2350–2355. doi:10.1111/j.1532-5415.2011.03713.x
   PubMed Web of Science ®Google Scholar
• Ravosa MJ, Ning J, Liu Y, Stack MS. Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts. Arch Oral Biol. 2011;56(5):491–498. doi:10.1016/j.archoralbio.2010.11.003
   Web of Science ®Google Scholar
• Pan B, To LB, Farrugia AN, et al. The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone. 2004;34(1):112–123. doi:10.1016/j.bone.2003.08.013
   Web of Science ®Google Scholar
• Agis H, Blei J, Watzek G, Gruber R. Is zoledronate toxic to human periodontal fibroblasts? J Dent Res. 2010;89(1):40–45. doi:10.1177/0022034509354298
   Web of Science ®Google Scholar
• Ohnuki H, Izumi K, Terada M, et al. Zoledronic acid induces S-phase arrest via a DNA damage response in normal human oral keratinocytes. Arch Oral Biol. 2012;57(7):906–917. doi:10.1016/j.archoralbio.2011.11.015
   Web of Science ®Google Scholar
• Wang L, Liu S, Zhao Y, et al. Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass. Cell Death Differ. 2015;22(10):1654–1664. doi:10.1038/cdd.2015.14
   Web of Science ®Google Scholar
• Chen X, Wang Z, Duan N, Zhu G, Schwarz EM, Xie C. Osteoblast–osteoclast interactions. Connect Tissue Res. 2018;59(2):99–107. doi:10.1080/03008207.2017.1290085
   PubMed Web of Science ®Google Scholar
• Schindeler A, Little DG. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro. Biochem Biophys Res Commun. 2005;338(2):710–716. doi:10.1016/j.bbrc.2005.09.198
   PubMed Web of Science ®Google Scholar
• Patntirapong S, Singhatanadgit W, Chanruangvanit C, Lavanrattanakul K, Satravaha Y. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition. J Oral Pathol Med. 2012;41(9):713–720. doi:10.1111/j.1600-0714.2012.01154.x
   Web of Science ®Google Scholar
• Long LH, Hoi A, Halliwell B. Instability of, and generation of hydrogen peroxide by, phenolic compounds in cell culture media. Arch Biochem Biophys. 2010;501:162–169. doi:10.1016/j.abb.2010.06.012
   PubMed Web of Science ®Google Scholar
• Rodemeister S, Hill K. Pyruvate diminishes the cytotoxic activity of ascorbic acid in several tumor cell lines in vitro. Biochem Biophys Res Commun. 2017;493(3):1184–1189. doi:10.1016/j.bbrc.2017.09.138
   PubMed Web of Science ®Google Scholar
• Kelts JL, Cali JJ, Duellman SJ, Shultz J. Altered cytotoxicity of ROS-inducing compounds by sodium pyruvate in cell culture medium depends on the location of ROS generation. Springerplus. 2015;4(1):1–8. doi:10.1186/s40064-015-1063-y
   Google Scholar
• Wee LM, Long LH, Whiteman M, Halliwell B. Factors affecting the ascorbate- and phenolic-dependent generation of hydrogen peroxide in Dulbecco’s modified Eagles Medium. Free Radic Res. 2003;37(10):1123–1130. doi:10.1080/10715760310001607041
   PubMed Web of Science ®Google Scholar
• Fatokun AA, Stone TW, Smith RA. Responses of differentiated MC3T3-E1 osteoblast-like cells to reactive oxygen species. Eur J Pharmacol. 2008;587(13):35–41. doi:10.1016/j.ejphar.2008.03.024
   Web of Science ®Google Scholar
• Heufelder MJ, Hendricks J, Remmerbach T, Frerich B, Hemprich A, Wilde F. Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:e429e435. doi:10.1016/j.oooo.2012.08.442
   Web of Science ®Google Scholar
• Bermúdez-Bejarano EB, Serrera-Figallo MÁ, Gutiérrez-Corrales A, et al. Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates. J Clin Exp Dent. 2017;9(1):e141e149. doi:10.4317/jced.53372
   Google Scholar
• Zafar S, Coates DE, Cullinan MP, Drummond BK, Milne T, Seymour GJ. Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts. Clin Oral Investig. 2016;20(8):2023–2035. doi:10.1007/s00784-015-1706-y
   PubMed Web of Science ®Google Scholar
• Ziebart T, Koch F, Klein MO, et al. Geranylgeraniol - A new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw. Oral Oncol. 2011;47:195–201. doi:10.1016/j.oraloncology.2010.12.003
   Web of Science ®Google Scholar
• Martins MAT, Martins MD, Lascala CA, et al. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: A preliminary study. Oral Oncol. 2012;48(1):79–84. doi:10.1016/j.oraloncology.2011.08.010
   PubMed Web of Science ®Google Scholar
• Pansani TN, Basso FG, Turirioni APS, Kurachi C, Hebling J, de Souza Costa CA. Effects of low-level laser therapy on the proliferation and apoptosis of gingival fibroblasts treated with zoledronic acid. Int J Oral Maxillofac Surg. 2014;43(8):1030–1034. doi:10.1016/j.ijom.2014.02.011
   Web of Science ®Google Scholar
• Draenert GF, Huetzen DO, Kämmerer PW, Palarie V, Nacu V, Wagner W. Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo. J Cranio-Maxillofacial Surg. 2012;40(8):e369e374. doi:10.1016/j.jcms.2012.01.028
   Web of Science ®Google Scholar
• Ersan N, Van Ruijven LJ, Bronckers ALJJ, Olgaç V, Ilgüy D, Everts V. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: A rat model. Dentomaxillofacial Radiol. 2014;43:1. doi:10.1259/dmfr.20130144
   Web of Science ®Google Scholar
• Dayisoylu EH, FÇ Ş, Üngör C, et al. The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study. Int J Oral Maxillofac Surg. 2013;42(11):1475–1480. doi:10.1016/j.ijom.2013.05.001
   PubMed Web of Science ®Google Scholar
• Sarkarat F, Motamedi MHK, Jahanbani J, Sepehri D, Kahali R, Nematollahi Z. Platelet-rich plasma in treatment of zoledronic acid-induced bisphosphonate-related osteonecrosis of the jaws. Trauma Mon. 2014;19(2):13–17. doi:10.5812/traumamon.17196
   Google Scholar
• Mergoni G, Vescovi P, Sala R, et al. The effect of laser therapy on the expression of osteocalcin and osteopontin after tooth extraction in rats treated with zoledronate and dexamethasone. Support Care Cancer. 2016;24(2):807–813. doi:10.1007/s00520-015-2847-x
   Web of Science ®Google Scholar